144 related articles for article (PubMed ID: 16455704)
1. NEJM editor gives pretrial evidence in Vioxx case.
Tanne JH
BMJ; 2006 Feb; 332(7536):255. PubMed ID: 16455704
[No Abstract] [Full Text] [Related]
2. Merck VIOXX "warning" is questioned.
Allen TS; Henderson JH
Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
[No Abstract] [Full Text] [Related]
3. Merck cleared in personal injury case against Vioxx.
Mayor S
BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390
[No Abstract] [Full Text] [Related]
4. The lessons of Vioxx--drug safety and sales.
Waxman HA
N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862
[No Abstract] [Full Text] [Related]
5. Vioxx doctors wooed by Merck are now its foes.
Tesoriero HW
Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
[No Abstract] [Full Text] [Related]
6. Medical journal criticizes Merck over Vioxx data.
Berenson A
N Y Times Web; 2005 Dec; ():A1, C13. PubMed ID: 16456990
[No Abstract] [Full Text] [Related]
7. Will Merck survive Vioxx?
Simons J; Stipp D
Fortune; 2004 Nov; 150(9):90-2, 94, 96-7 passim. PubMed ID: 15543824
[No Abstract] [Full Text] [Related]
8. COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
Fendrick AM
Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263
[No Abstract] [Full Text] [Related]
9. Failing the public health--rofecoxib, Merck, and the FDA.
Topol EJ
N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
[No Abstract] [Full Text] [Related]
10. Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Couzin J
Science; 2005 Dec; 310(5755):1755. PubMed ID: 16357236
[No Abstract] [Full Text] [Related]
11. Despite warnings, drug giant took long path to Vioxx recall.
Berenson A; Harris G; Meier B; Pollack A
N Y Times Web; 2004 Nov; ():A1, A32. PubMed ID: 15599982
[No Abstract] [Full Text] [Related]
12. Manipulating a journal article.
N Y Times Web; 2005 Dec; ():WK11. PubMed ID: 16453395
[No Abstract] [Full Text] [Related]
13. Causation, Vioxx, and legal issues.
Green MD
Science; 2005 Nov; 310(5750):973. PubMed ID: 16284163
[No Abstract] [Full Text] [Related]
14. How Vioxx is changing US drug regulation.
Zwillich T
Lancet; 2005 Nov; 366(9499):1763-4. PubMed ID: 16302300
[No Abstract] [Full Text] [Related]
15. Quebec allows Vioxx class-action suit.
Sibbald B
CMAJ; 2007 Jan; 176(1):20. PubMed ID: 17200378
[No Abstract] [Full Text] [Related]
16. Vioxx award good news for Canadian lawsuits.
Eggertson L
CMAJ; 2005 Sep; 173(7):744. PubMed ID: 16186576
[No Abstract] [Full Text] [Related]
17. The Vioxx debacle revisited.
Abeles M; Abeles AM
Am J Med; 2005 Sep; 118(9):1057-8. PubMed ID: 16164907
[No Abstract] [Full Text] [Related]
18. The law. Vioxx verdict: too little or too much science?
Lawler A
Science; 2005 Sep; 309(5740):1481. PubMed ID: 16141043
[No Abstract] [Full Text] [Related]
19. How to avoid another 'Vioxx'.
Frantz S
Nat Rev Drug Discov; 2005 Jan; 4(1):5-7. PubMed ID: 15690595
[No Abstract] [Full Text] [Related]
20. Merck withdraws Vioxx; FDA issues public health advisory.
FDA Consum; 2004; 38(6):11. PubMed ID: 15675020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
